Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy
Background: Early brainstem neurodegeneration is common in Parkinson's disease (PD) and progressive supranuclear palsy (PSP). While previous work showed abnormalities in vestibular evoked myogenic potentials (VEMPs) in patients with either disorder as compared to healthy humans, it remains uncl...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2020.598763/full |
id |
doaj-a7c6f85eb33c42178c849896e012b5ca |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Sandra Carpinelli Philipp O. Valko Philipp O. Valko Daniel Waldvogel Elena Buffone Christian R. Baumann Christian R. Baumann Dominik Straumann Esther Werth Esther Werth Christopher J. Bockisch Christopher J. Bockisch Christopher J. Bockisch Konrad P. Weber Konrad P. Weber Yulia Valko Yulia Valko |
spellingShingle |
Sandra Carpinelli Philipp O. Valko Philipp O. Valko Daniel Waldvogel Elena Buffone Christian R. Baumann Christian R. Baumann Dominik Straumann Esther Werth Esther Werth Christopher J. Bockisch Christopher J. Bockisch Christopher J. Bockisch Konrad P. Weber Konrad P. Weber Yulia Valko Yulia Valko Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy Frontiers in Neurology vestibular evoked myogenic potentials oVEMP cVEMP Parkinson disease progressive supranuclear palsy |
author_facet |
Sandra Carpinelli Philipp O. Valko Philipp O. Valko Daniel Waldvogel Elena Buffone Christian R. Baumann Christian R. Baumann Dominik Straumann Esther Werth Esther Werth Christopher J. Bockisch Christopher J. Bockisch Christopher J. Bockisch Konrad P. Weber Konrad P. Weber Yulia Valko Yulia Valko |
author_sort |
Sandra Carpinelli |
title |
Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy |
title_short |
Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy |
title_full |
Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy |
title_fullStr |
Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy |
title_full_unstemmed |
Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear Palsy |
title_sort |
distinct vestibular evoked myogenic potentials in patients with parkinson disease and progressive supranuclear palsy |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Neurology |
issn |
1664-2295 |
publishDate |
2021-02-01 |
description |
Background: Early brainstem neurodegeneration is common in Parkinson's disease (PD) and progressive supranuclear palsy (PSP). While previous work showed abnormalities in vestibular evoked myogenic potentials (VEMPs) in patients with either disorder as compared to healthy humans, it remains unclear whether ocular and cervical VEMPs differ between PD and PSP patients.Methods: We prospectively included 12 PD and 11 PSP patients, performed ocular and cervical VEMPs, and calculated specific VEMP scores (0 = normal, 12 = most pathological) based on latencies, amplitude, and absent responses. In addition, we assessed disease duration, presence of imbalance, motor asymmetry, and motor disability using the Movement Disorder Society Unified Parkinson's Disease Rating Scale, part III (MDS-UPDRS III). Moreover, we ascertained various sleep parameters by video-polysomnography.Results: PSP and PD patients had similar oVEMP scores (6 [3–6] vs. 3 [1.3–6], p = 0.06), but PSP patients had higher cVEMP scores (3 [0–6] vs. 0 [0–2.8], p = 0.03) and total VEMP scores (9 [5–12] vs. 4 [2–7.5], p = 0.01). Moreover, total VEMP scores >10 were only observed in PSP patients (45%, p = 0.01). MDS-UPDRS III correlated with cVEMP scores (rho = 0.77, p = 0.01) in PSP, but not in PD. In PD, but not in PSP, polysomnographic markers of disturbed sleep, including decreased rapid eye movement sleep, showed significant correlations with VEMP scores.Conclusions: Our findings suggest that central vestibular pathways are more severely damaged in PSP than in PD, as indicated by higher cervical and total VEMP scores in PSP than PD in a between-groups analysis. Meaningful correlations between VEMPs and motor and non-motor symptoms further encourage its use in neurodegenerative Parkinsonian syndromes. |
topic |
vestibular evoked myogenic potentials oVEMP cVEMP Parkinson disease progressive supranuclear palsy |
url |
https://www.frontiersin.org/articles/10.3389/fneur.2020.598763/full |
work_keys_str_mv |
AT sandracarpinelli distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT philippovalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT philippovalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT danielwaldvogel distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT elenabuffone distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT christianrbaumann distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT christianrbaumann distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT dominikstraumann distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT estherwerth distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT estherwerth distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT christopherjbockisch distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT christopherjbockisch distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT christopherjbockisch distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT konradpweber distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT konradpweber distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT yuliavalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy AT yuliavalko distinctvestibularevokedmyogenicpotentialsinpatientswithparkinsondiseaseandprogressivesupranuclearpalsy |
_version_ |
1724273766525042688 |
spelling |
doaj-a7c6f85eb33c42178c849896e012b5ca2021-02-12T04:44:23ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-02-011110.3389/fneur.2020.598763598763Distinct Vestibular Evoked Myogenic Potentials in Patients With Parkinson Disease and Progressive Supranuclear PalsySandra Carpinelli0Philipp O. Valko1Philipp O. Valko2Daniel Waldvogel3Elena Buffone4Christian R. Baumann5Christian R. Baumann6Dominik Straumann7Esther Werth8Esther Werth9Christopher J. Bockisch10Christopher J. Bockisch11Christopher J. Bockisch12Konrad P. Weber13Konrad P. Weber14Yulia Valko15Yulia Valko16Department of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSleep & Health Zurich, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSleep & Health Zurich, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandSleep & Health Zurich, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Otorhinolaryngology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Neurology, Clinical Neuroscience Center, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandDepartment of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, SwitzerlandBackground: Early brainstem neurodegeneration is common in Parkinson's disease (PD) and progressive supranuclear palsy (PSP). While previous work showed abnormalities in vestibular evoked myogenic potentials (VEMPs) in patients with either disorder as compared to healthy humans, it remains unclear whether ocular and cervical VEMPs differ between PD and PSP patients.Methods: We prospectively included 12 PD and 11 PSP patients, performed ocular and cervical VEMPs, and calculated specific VEMP scores (0 = normal, 12 = most pathological) based on latencies, amplitude, and absent responses. In addition, we assessed disease duration, presence of imbalance, motor asymmetry, and motor disability using the Movement Disorder Society Unified Parkinson's Disease Rating Scale, part III (MDS-UPDRS III). Moreover, we ascertained various sleep parameters by video-polysomnography.Results: PSP and PD patients had similar oVEMP scores (6 [3–6] vs. 3 [1.3–6], p = 0.06), but PSP patients had higher cVEMP scores (3 [0–6] vs. 0 [0–2.8], p = 0.03) and total VEMP scores (9 [5–12] vs. 4 [2–7.5], p = 0.01). Moreover, total VEMP scores >10 were only observed in PSP patients (45%, p = 0.01). MDS-UPDRS III correlated with cVEMP scores (rho = 0.77, p = 0.01) in PSP, but not in PD. In PD, but not in PSP, polysomnographic markers of disturbed sleep, including decreased rapid eye movement sleep, showed significant correlations with VEMP scores.Conclusions: Our findings suggest that central vestibular pathways are more severely damaged in PSP than in PD, as indicated by higher cervical and total VEMP scores in PSP than PD in a between-groups analysis. Meaningful correlations between VEMPs and motor and non-motor symptoms further encourage its use in neurodegenerative Parkinsonian syndromes.https://www.frontiersin.org/articles/10.3389/fneur.2020.598763/fullvestibular evoked myogenic potentialsoVEMPcVEMPParkinson diseaseprogressive supranuclear palsy |